Priveq and Investor divest Vårdapoteket

Apotek Hjärtat has signed an agreement to wholly acquire Vårdapoteket, subject to approval by the Swedish Medical Products Agency and the Swedish Competition Authority.

Apotek Hjärtat is the largest independent pharmacy chain after state-owned Apoteket AB, with slightly more than 270 pharmacies and around 2,000 employees.

Vårdapoteket and Apotek Hjärtat were said to complement each other with Vårdapoteket's focus on outpatient pharmacies and inpatient pharmacy deliveries and services, alongside national coverage at Apotek Hjärtat.

Segulah sold the Medstop pharmacy chain to Oriola-KD for €174m earlier in April.

Company
Vårdapoteket is a pharmacy operator with a focus on care-related pharmacies. It was created in connection with the Swedish state deregulation and privatisation of pharmacies in 2010.

Since inception, the chain has grown from 24 outpatient pharmacies to its current 27 pharmacies. Vårdapoteket has won four tender offers for inpatient pharmacy deliveries and services for county councils.

Vårdapoteket was the first player that broke the de facto monopoly that Apoteket AB held in the pharmaceutical market since deregulation in 2008.

People
Louise Nilsson is a partner and investment manager at Priveq and a member of the board of Vårdapoteket. Thomas Eklund is a managing director at Investor Growth and also a member of Vårdapoteket's board. Lars Gunneflo is CEO and member of the board of Vårdapoteket.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Nordics
• Exits
• Healthcare
• Now researching
• Sweden
• Priveq Partners
• Investor Growth Capital